შემადგენლობა

Angiogenin: 27 CH; Brain Derived Neurotrophic Factor (BDNF): 5 CH; Ciliary Neuro Trophic Factor (CNTF): 4 CH; Fibroblast Growth Factor Basic (bFGF): 9 CH; Insulin Growth Factor 1 (IGF-1): 17 CH; Interleukin 1 (IL-1): 17 CH; Macrophage Inflammatory Protein 1 Alpha (MIP-1α): 27 CH; Macrophage Inflammatory Protein 1 Beta (MIP-1β): 27 CH; Nerve Growth Factor (NGF): 4 CH; Pigment Derived Epithelial Factor (PDEF): 3 CH; Plateled Derived Endothelial Cell Growth Factor (PDECGF): 9 CH; Rantes: 27 CH; Substance P: 27 CH; Transforming Growth Factor Beta (TGF-β): 9 CH; Tumor Necrosis Factor Alpha (TNF-α): 17 CH; Specific Nucleic Acid SNA®-DMLAa-01: 18 CH; Specific Nucleic Acid SNA®-DMLAb-01: 18 CH;

ჩვენებები

2LDMLA – პრეპარატი გამოიუენება მაკულის დისტროფიის დროს

დოზირების ფორმები

1507 CH 129 F1 – CNK 2230-837

შეფუთვა

5 კაფსულა